59
Views
40
CrossRef citations to date
0
Altmetric
Original Article

Colorectal Dysplasia and Carcinoma in Patients with Ulcerative Colitis and Primary Sclerosing Cholangitis

, , , , &
Pages 706-711 | Received 30 Dec 1996, Accepted 17 Mar 1997, Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Ganglei Liu, Jingmei Lin, Hao Xie, Bo Shen, Luca Stocchi & Xiuli Liu. (2015) Histomorphological features and prognosis of colitis-associated colorectal cancer in patients with primary sclerosing cholangitis. Scandinavian Journal of Gastroenterology 50:11, pages 1389-1396.
Read now

Articles from other publishers (39)

Mohamed Attauabi, Mirabella Zhao, Flemming Bendtsen & Johan Burisch. (2021) Systematic Review with Meta-analysis: The Impact of Co-occurring Immune-mediated Inflammatory Diseases on the Disease Course of Inflammatory Bowel Diseases. Inflammatory Bowel Diseases 27:6, pages 927-939.
Crossref
Shun Murasugi, Ayumi Ito, Teppei Omori, Shinichi Nakamura & Katsutoshi Tokushige. (2020) Clinical Characterization of Ulcerative Colitis in Patients with Primary Sclerosing Cholangitis. Gastroenterology Research and Practice 2020, pages 1-8.
Crossref
Paul Collins, Bret A. Lashner & Alastair J.M. Watson. 2019. Evidence-based Gastroenterology and Hepatology 4e. Evidence-based Gastroenterology and Hepatology 4e 258 270 .
Bhavana Bhagya Rao, Bret Lashner & Kris V Kowdley. (2018) Reviewing the Risk of Colorectal Cancer in Inflammatory Bowel Disease After Liver Transplantation for Primary Sclerosing Cholangitis. Inflammatory Bowel Diseases 24:2, pages 269-276.
Crossref
Carolina Palmela, Farhad Peerani, Daniel Castaneda, Joana Torres & Steven H. Itzkowitz. (2018) Inflammatory Bowel Disease and Primary Sclerosing Cholangitis: A Review of the Phenotype and Associated Specific Features. Gut and Liver 12:1, pages 17-29.
Crossref
Mary Shuhaibar & Colm O’Morain. (2017) Colorectal Malignancy in a Prospective Irish Inflammatory Bowel Disease Population 15 Years Since Diagnosis: Comparison with the EC-IBD Cohort. Gastroenterology Research and Practice 2017, pages 1-7.
Crossref
Roman Zenouzi, Tobias J. Weismüller, Kristin K. Jørgensen, Michael Bubenheim, Henrike Lenzen, Peter Hübener, Kornelius Schulze, Christina Weiler-Normann, Marcial Sebode, Hanno Ehlken, Nadine Pannicke, Johannes Hartl, Moritz Peiseler, Sina Hübener, Tom H. Karlsen, Kirsten M. Boberg, Michael P. Manns, Ansgar W. Lohse & Christoph Schramm. (2016) No Evidence That Azathioprine Increases Risk of Cholangiocarcinoma in Patients With Primary Sclerosing Cholangitis. Clinical Gastroenterology and Hepatology 14:12, pages 1806-1812.
Crossref
Han-Han Zheng & Xue-Liang Jiang. (2016) Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and inflammatory bowel disease. European Journal of Gastroenterology & Hepatology 28:4, pages 383-390.
Crossref
Trine Folseraas & Kirsten Muri Boberg. (2016) Cancer Risk and Surveillance in Primary Sclerosing Cholangitis. Clinics in Liver Disease 20:1, pages 79-98.
Crossref
Ashokkumar Jain, Zakiyah Kadry, Stephanie L. Buchman & Ali Riaz Shah. 2016. Disease Recurrence After Liver Transplantation. Disease Recurrence After Liver Transplantation 215 231 .
A Boudewijn de Vries. (2015) Distinctive inflammatory bowel disease phenotype in primary sclerosing cholangitis. World Journal of Gastroenterology 21:6, pages 1956.
Crossref
Roman Zenouzi, Tobias J. Weismüller, Peter Hübener, Kornelius Schulze, Michael Bubenheim, Nadine Pannicke, Christina Weiler–Normann, Henrike Lenzen, Michael P. Manns, Ansgar W. Lohse & Christoph Schramm. (2014) Low Risk of Hepatocellular Carcinoma in Patients With Primary Sclerosing Cholangitis With Cirrhosis. Clinical Gastroenterology and Hepatology 12:10, pages 1733-1738.
Crossref
Christos Tsaitas. (2014) Update on inflammatory bowel disease in patients with primary sclerosing cholangitis. World Journal of Hepatology 6:4, pages 178.
Crossref
Urpo Nieminen, Airi Jussila, Stig Nordling, Harri Mustonen & Martti A. Färkkilä. (2014) Inflammation and disease duration have a cumulative effect on the risk of dysplasia and carcinoma in IBD: A case-control observational study based on registry data. International Journal of Cancer 134:1, pages 189-196.
Crossref
Nataliya Razumilava, Gregory J. Gores & Keith D. Lindor. (2011) Cancer surveillance in patients with primary sclerosing cholangitis. Hepatology 54:5, pages 1842-1852.
Crossref
Konstantinos H. Katsanos, Athina Tatsioni, Natalia Pedersen, Mary Shuhaibar, Vicent Hernandez Ramirez, Patrizia Politi, Evelien Rombrechts, Marieke Pierik, Juan Clofent, Marina Beltrami, Paolo Bodini, Joao Freitas, Ioannis Mouzas, Giovanni Fornaciari, Bjorn Moum, Peter Laszlo Lakatos, Severine Vermeire, Ebbe Langholz, Selwyn Odes, Colm O'. Morain, Reinhold Stockbrügger, Pia Munkholm & Epameinondas V. Tsianos. (2011) Cancer in inflammatory bowel disease 15years after diagnosis in a population-based European Collaborative follow-up study. Journal of Crohn's and Colitis 5:5, pages 430-442.
Crossref
J. Torres, G. Pineton de Chambrun, S. Itzkowitz, D. B. Sachar & J.-F. Colombel. (2011) Review article: colorectal neoplasia in patients with primary sclerosing cholangitis and inflammatory bowel disease. Alimentary Pharmacology & Therapeutics 34:5, pages 497-508.
Crossref
Byong Duk Ye, Suk-Kyun Yang, Sun-Jin Boo, Yun Kyung Cho, Dong-Hoon Yang, Soon Man Yoon, Kyung Jo Kim, Jeong-Sik Byeon, Seung-Jae Myung, Chang Sik Yu, Sung-Cheol Yun & Jin-Ho Kim. (2011) Clinical characteristics of ulcerative colitis associated with primary sclerosing cholangitis in Korea. Inflammatory Bowel Diseases 17:9, pages 1901-1906.
Crossref
Kwang Chin & Kamarjit Mangat. (2009) Radiofrequency Ablation of Colorectal Liver Metastases in a Transplanted Liver. CardioVascular and Interventional Radiology 32:5, pages 1114-1116.
Crossref
Taiga Nishihori, Mario Strazzabosco & Muhammad Wasif Saif. (2008) Incidence and Management of Colorectal Cancer in Liver Transplant Recipients. Clinical Colorectal Cancer 7:4, pages 260-266.
Crossref
Harry Sokol, Jacques Cosnes, Olivier Chazouilleres, Laurent Beaugerie, Emmanuel Tiret, Raoul Poupon & Philippe Seksik. (2008) Disease activity and cancer risk in inflammatory bowel disease associated with primary sclerosing cholangitis. World Journal of Gastroenterology 14:22, pages 3497.
Crossref
ROGER STENLING, JAN LINDBERG, JÖRGEN RUTEGÅRD & RICHARD PALMQVIST. (2007) Altered expression of CK7 and CK20 in preneoplastic and neoplastic lesions in ulcerative colitis. APMIS 115:11, pages 1219-1226.
Crossref
Gilaad G. Kaplan, Steven J. Heitman, Robert J. Hilsden, Stefan Urbanski, Robert P. Myers, Samuel S. Lee, Kelly W. Burak, Mark Swain & Remo Panaccione. (2007) Population-based analysis of practices and costs of surveillance for colonic dysplasia in patients with primary sclerosing cholangitis and colitis. Inflammatory Bowel Diseases 13:11, pages 1401-1407.
Crossref
Sabine Kersting, Matthias Bruewer, Mike G. Laukoetter, Emile M. Rijcken, Rudolf Mennigen, Horst Buerger, Norbert Senninger & Christian F. Krieglstein. (2006) Intestinal cancer in patients with Crohn’s disease. International Journal of Colorectal Disease 22:4, pages 411-417.
Crossref
K.H. Katsanos, D.K. Christodoulou, M. Michael, Elli Ioachim, G.V. Tsianos, Niki Agnantis & E.V. Tsianos. (2005) Inflammatory bowel disease-related dysplasia and cancer: A referral center study in northwestern Greece. European Journal of Internal Medicine 16:3, pages 170-175.
Crossref
S. N. Cullen & R. W. Chapman. (2005) Review article: current management of primary sclerosing cholangitis. Alimentary Pharmacology and Therapeutics 21:8, pages 933-948.
Crossref
Kazuo Tarao, Shigetoshi Fujiyama, Shinichi Ohkawa, Kaoru Miyakawa, Setsuo Tamai, Satoru Hirokawa, Takahiro Masaki & Katsuaki Tanaka. (2005) Ursodiol Use Is Possibly Associated with Lower Incidence of Hepatocellular Carcinoma in Hepatitis C Virus–Associated Liver Cirrhosis. Cancer Epidemiology, Biomarkers & Prevention 14:1, pages 164-169.
Crossref
Uma Mahadevan & William J. Sandborn. 2005. Inflammatory Bowel Disease: From Bench to Bedside. Inflammatory Bowel Disease: From Bench to Bedside 643 658 .
Darrell S. Pardi, Edward V. LoftusJrJr, Walter K. Kremers, Jill Keach & Keith D. Lindor. (2003) Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis. Gastroenterology 124:4, pages 889-893.
Crossref
Uma Mahadevan & William J. Sandborn. 2003. Inflammatory Bowel Disease: From Bench to Bedside. Inflammatory Bowel Disease: From Bench to Bedside 643 658 .
Roy M. Soetikno, Otto S. Lin, Paul A. Heidenreich, Harvey S. Young & Michael O. Blackstone. (2002) Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis: A meta-analysis. Gastrointestinal Endoscopy 56:1, pages 48-54.
Crossref
Sara D’Innocenzo, Francesca Russo, Lucia Miglioresi, Marco Bacosi & Giovanni L. Ricci. 2002. Advances in Abdominal Surgery 2002. Advances in Abdominal Surgery 2002 67 84 .
J Fung. (2001) De novo malignancies after liver transplantation: A major cause of late death. Liver Transplantation 7:11, pages S109-S118.
Crossref
K. Holzmann, B. Klump, F. Borchard, M. Gregor & R. Porschen. (2001) Flow cytometric and histologic evaluation in a large cohort of patients with ulcerative colitis. Diseases of the Colon & Rectum 44:10, pages 1446-1455.
Crossref
Annika Bergquist & Ulrika Broomé. (2001) Hepatobiliary and extra-hepatic malignancies in primary sclerosing cholangitis. Best Practice & Research Clinical Gastroenterology 15:4, pages 643-656.
Crossref
Marjut Leidenius, Krister Höckerstedt, Ulrika Broomé, Bo-Göran Ericzon, Styrbjörn Friman, Michael Olausson & Erik Schrumpf. (2001) Hepatobiliary carcinoma in primary sclerosing cholangitis: a case control study. Journal of Hepatology 34:6, pages 792-798.
Crossref
Bo U. Lindberg, Ulrika Broomé & Bo Persson. (2001) Proximal colorectal dysplasia or cancer in ulcerative colitis. The impact of primary sclerosing cholangitis and sulfasalazine. Diseases of the Colon & Rectum 44:1, pages 77-83.
Crossref
U. Broomé & A. Bergquist. 2000. Immunology and Liver. Immunology and Liver 296 307 .
Marco Bacosi, Marco Delle Monache, Francesca Russo & Giovanni L. Ricci. 1999. Advances in Abdominal Surgery. Advances in Abdominal Surgery 197 221 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.